IDEXX Laboratories, Inc. (IDXX) Balance Sheet
As of 2026-06-30 (10-Q), IDEXX Laboratories, Inc. (IDXX) reported total assets of $3.4B, total liabilities of $1.8B and shareholders' equity of $1.6B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $196.9M. Long-term debt: $299.9M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
IDXXIDEXX Laboratories, Inc.Follow IDXX — free
—
Price chart with a free account
- Market cap
- 44.1B
- P/E TTM
- 39.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
| Line | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Jan 18 | FY2018 Jan 19 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.16 | 0.18 | 0.22 | 0.28 | 0.32 | 0.13 | 0.15 | 0.19 | 0.12 | 0.09 | 0.38 | 0.14 | 0.11 | 0.45 | 0.29 | 0.18 | 0.20 | |
| Short-term investments | — | — | — | — | — | 0.21 | 0.24 | 0.28 | — | — | — | — | — | — | — | — | — | |
| Receivables | 0.12 | 0.14 | 0.14 | 0.16 | 0.15 | 0.19 | 0.20 | 0.24 | 0.25 | 0.27 | 0.33 | 0.37 | 0.40 | 0.46 | 0.47 | 0.55 | 0.63 | |
| Inventory | 0.13 | 0.13 | 0.14 | 0.13 | 0.16 | 0.19 | 0.16 | 0.16 | 0.17 | 0.20 | 0.21 | 0.27 | 0.37 | 0.38 | 0.38 | 0.38 | 0.39 | |
| Current assets | 0.46 | 0.52 | 0.57 | 0.65 | 0.76 | 0.82 | 0.85 | 0.97 | 0.65 | 0.68 | 1.06 | 0.96 | 1.10 | 1.50 | 1.40 | 1.41 | 1.51 | |
| Total assets | 0.90 | 1.03 | 1.10 | 1.23 | 1.38 | 1.47 | 1.53 | 1.74 | 1.62 | 1.83 | 2.29 | 2.44 | 2.75 | 3.26 | 3.29 | 3.35 | 3.44 | |
| Current liabilities | 0.29 | 0.44 | 0.41 | 0.48 | 0.82 | 0.86 | 0.93 | 1.00 | 0.78 | 0.73 | 0.58 | 0.76 | 1.24 | 0.95 | 1.07 | 1.15 | 1.29 | |
| Long-term debt | — | 0.00 | 0.00 | 0.15 | 0.35 | 0.60 | 0.59 | 0.61 | 0.60 | 0.70 | 0.91 | 0.85 | 0.69 | 0.62 | 0.45 | 0.37 | 0.30 | |
| Short-term debt | — | — | — | — | — | — | — | — | — | 0.00 | 0.05 | 0.07 | 0.07 | 0.07 | 0.17 | 0.07 | 0.15 | |
| Total liabilities | 0.32 | 0.49 | 0.47 | 0.71 | 1.27 | 1.56 | 1.64 | 1.80 | 1.63 | 1.65 | 1.66 | 1.75 | 2.14 | 1.78 | 1.70 | 1.75 | 1.83 | |
| Shareholders' equity | 0.57 | 0.54 | 0.64 | 0.52 | 0.12 | -0.08 | -0.11 | -0.05 | -0.01 | 0.18 | 0.63 | 0.69 | 0.61 | 1.48 | 1.60 | 1.61 | 1.61 |
USD billions · SEC XBRL
IDEXX Laboratories, Inc. — questions
- How much cash does IDEXX Laboratories, Inc. have?
- $196.9M in cash and cash equivalents as of 2026-06-30.
- How much debt does IDEXX Laboratories, Inc. have?
- $299.9M of long-term debt and $150.0M due within a year as of 2026-06-30.
- What are IDEXX Laboratories, Inc.'s total assets?
- $3.4B as of 2026-06-30.
- What is IDEXX Laboratories, Inc.'s shareholders' equity?
- $1.6B as of 2026-06-30.
Every figure on this page comes from IDEXX Laboratories, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.